Neurofluidics, based in Menlo Park, CA, is an industrial start-up specializing in providing human cell-based assays for pharmaceutical, nutrition, and dermo-cosmetics industries. Their innovative approach involves utilizing high-throughput microfluidic devices and R&D services to digitize the human body, offering predictive data and platforms to understand modes of action in discovery, preclinical, and clinical phases.
NETRI's holistic methodology integrates organs-on-chip technologies into standardized processes, bridging the gap between laboratory discovery, human biology, and pathophysiology. From developing treatment solutions to supporting clients throughout product development, NETRI's expertise lies in cataloging and deciphering the complex language of human neurons for a wide range of applications.
Generated from the website